Tags : EMA Rolling Review

Regulatory

GSK and Vir Report Initiation of EMA Rolling Review of

Shots: The rolling review will assess sotrovimab in adults and adolescents (aged 12yrs.) with COVID-19 who do not require oxygen supplementation and who are at risk of progressing to severe COVID-19. The rolling review will support a formal MAA EMA’s CHMP will review the data and the decision to start the rolling review is based […]Read More